| Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
|---|
| 08/01/2002 | WO2002059081A2 Urea derivatives as inhibitors of ccr-3 receptor |
| 08/01/2002 | WO2002059080A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| 08/01/2002 | WO2002059077A1 Aminoethanol derivatives |
| 08/01/2002 | WO2002002505A3 Compounds to treat alzheimer's disease |
| 08/01/2002 | US20020103380 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 08/01/2002 | US20020103171 7-and 9- carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 08/01/2002 | US20020100127 Novel coupler for use in oxidative hair dyeing |
| 08/01/2002 | CA2435829A1 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| 08/01/2002 | CA2435647A1 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 07/31/2002 | EP1226112A2 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 07/30/2002 | US6426434 Reacting ammonia and carbon dioxide to form urea, followed by separation of unreacted ammonia and carbon dioxide by stripping with carbon dioxide at a pressure equal to the urea synthesis pressure and by high and low pressure decomposition |
| 07/30/2002 | CA2151728C Monomer containing at least one isocyanate group and one insaturation; process for synthesizing the same and (co)polymers derived from said monomer |
| 07/30/2002 | CA2148683C Potentiator of bacillus pesticidal activity |
| 07/25/2002 | WO2002057242A2 Urea derivatives as integrin alpha 4 antagonists |
| 07/25/2002 | WO2002057233A1 Mch antagonists and their use in the treatment of obesity |
| 07/25/2002 | WO2002030874A3 Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
| 07/25/2002 | WO2001040188A9 Curcumin analogues for treating cancer |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | CA2434939A1 Urea derivatives as integrin alpha 4 antagonists |
| 07/24/2002 | EP1224165A1 Novel compounds |
| 07/24/2002 | EP1223921A2 Tissue factor antagonists and methods of use thereof |
| 07/23/2002 | US6423870 Tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 07/23/2002 | US6423854 Aminophenol derivatives and their use in cosmetics |
| 07/23/2002 | US6423753 Controlling angiogenesis |
| 07/18/2002 | US20020095050 Phenylserine derivatives as integrin antagonists |
| 07/18/2002 | US20020094342 Contacting skin with skin treatment composition having concentration of 1-(3-methoxybenzyl)-3-substituted thiourea compound effective for inhibiting free radical generation |
| 07/17/2002 | EP1222163A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds |
| 07/17/2002 | EP1039902A4 Inhibitors of gap junction communication |
| 07/17/2002 | CN1359373A 6[(aryl and heteroaryl)oxy] methyl] naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 07/16/2002 | US6420466 Process for preparing a thixotropic agent and its use |
| 07/16/2002 | US6420396 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 07/16/2002 | US6420324 Dispersion of hydrophoic solid urea derivatives with organic oil, mineral oil, a siloxane, and/or an organomodified siloxane; small spherical crystals; long lasting |
| 07/11/2002 | WO2002053534A1 Vla-4 inhibitors |
| 07/11/2002 | WO2002053523A1 Tropolone derivative |
| 07/11/2002 | WO2000073263A9 Cytofectin dimers and methods of use thereof |
| 07/11/2002 | WO2000064911A9 Ligands for metabotropic glutamate receptors |
| 07/11/2002 | CA2432409A1 Tropolone derivative |
| 07/10/2002 | EP1220836A2 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 07/09/2002 | US6417393 Treatment of sickle-cell anemia, brain edema from tumors or ischemia, diarrhea, and glaucoma; hypotensive, wound healing, antiinflammatory and antiallergen agents |
| 07/09/2002 | US6417361 Fluorination agent and preparation and use of same |
| 07/09/2002 | CA2133218C Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase |
| 07/09/2002 | CA2094137C Novel hydroxamic acid and n-hydroxyurea derivatives and their use |
| 07/04/2002 | WO2002051810A2 Integrin receptor ligands |
| 07/04/2002 | WO2002051799A1 Biphenyl derivatives |
| 07/04/2002 | WO2002022627A3 Ligands for metabotropic glutamate receptors |
| 07/04/2002 | WO2001092213A3 Excitatory amino acid receptor modulators |
| 07/04/2002 | US20020087009 Intermediates for (r)-3(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-h-imidazo[1,2-a] imidazol-2-one |
| 07/04/2002 | US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates |
| 07/04/2002 | US20020085965 From pure ammonia and carbon dioxide; high conversion yield with reduced energy consumption and low implementation costs. |
| 07/03/2002 | EP1218336A2 Melanin concentrating hormone antagonist |
| 07/03/2002 | EP1037871B1 Novel antiarrhythmic compounds |
| 07/03/2002 | EP0681573B1 C2 Taxane derivatives and pharmaceutical compositions containing them |
| 07/03/2002 | CN1356977A Glucagon antagonists/inverse agonists |
| 07/02/2002 | US6414184 Process for producing polyisocyanates containing biuret groups from (cyclo)aliphatic diisocyanates |
| 07/02/2002 | US6414161 Chemical intermediate in preparation of small molecules that inhibit interaction of celluar adhesion molecules thereby treating or preventing inflammatory and immune cell-mediated disease |
| 06/27/2002 | WO2002050052A1 N-acyl aminoacetonitriles having pesticidal properties |
| 06/27/2002 | WO2002050019A2 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | WO2002024613A3 Resorcinol derivatives |
| 06/27/2002 | WO2002022592A3 Substituted urea neuropeptide y y5 receptor antagonists |
| 06/27/2002 | WO2002018323A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 06/27/2002 | US20020082451 Process for the synthesis of urea |
| 06/27/2002 | US20020082441 Useful as an intermediate in preparation of certain small molecules that are useful in therapy or prophylaxis of inflammatory and immune cell-mediated diseases |
| 06/27/2002 | US20020082257 Elevates ATP binding cassette transporter 1 expression thereby increasing efflux of cholesterol from cells by active transfer into high density lipoproteins |
| 06/27/2002 | CA2432908A1 Diamines as modulators of chemokine receptor activity |
| 06/26/2002 | EP1216225A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 06/26/2002 | EP1216223A1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 06/26/2002 | EP0894084B1 Cinnamic acid derivatives and their use as integrin antagonists |
| 06/26/2002 | CN1355811A Integrain receptor antagaonists |
| 06/25/2002 | US6410585 Therapy for non-insulin depend diabetes |
| 06/20/2002 | WO2002048099A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 06/20/2002 | WO2002012243A3 SYNTHESIS OF (R)-3-(4-BROMOBENZYL)-1-(3,5-DICHLOROPHENYL)-5-IODO-3-METHYL-1-H-IMIDAZO[1,2-a]IMIDAZOL-2-ONE |
| 06/20/2002 | DE10063008A1 Carbonsäureamidderivate Carboxamide |
| 06/20/2002 | CA2431766A1 Carboxymide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 06/19/2002 | EP1214293A1 Non-peptidic cyclophilin binding compounds and their use |
| 06/19/2002 | CN1354170A New process for synthesizing diethylbarbituric acid by using sodium methoxide as catalyst |
| 06/18/2002 | US6407065 VLA-4 antagonists |
| 06/18/2002 | US6406691 Potentiator of Bacillus pesticidal activity |
| 06/13/2002 | WO2002046181A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046172A2 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046146A1 Substituted carboxylic acid derivatives |
| 06/13/2002 | WO2002046141A2 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO1999059957A9 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 06/13/2002 | US20020072615 Useful as intermediate in the preparation of certain small molecules that are useful in therapy or prophylaxis of inflammatory and immune cell-mediated disease |
| 06/13/2002 | US20020072610 Useful as an intermediate in the preparation of certain small molecules that are useful in therapy or prophylaxis of inflammatory and immune cell-mediated diseases |
| 06/13/2002 | US20020072516 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders |
| 06/13/2002 | CA2436662A1 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2431005A1 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2430951A1 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/12/2002 | EP1212292A1 (-)-verbenone derivatives |
| 06/11/2002 | US6403738 Polymerization of olefins |
| 06/11/2002 | US6403600 Fungicides. |
| 06/11/2002 | CA2156439C Urea-surfactant clathrates and their use in bioremediation of hydrocarbon contaminated soils and water |
| 06/06/2002 | WO2002044126A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
| 06/06/2002 | WO2002004406A3 9-substituted minocycline compounds |
| 06/06/2002 | WO2001085681A3 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same |
| 06/06/2002 | US20020068763 N-substituted-N'-substituted urea derivative is used as a tumor necrosis factor-alpha production inhibitory agent and a therapeutical agent for autoimmune diseases |
| 06/06/2002 | CA2430409A1 Bisubstituted carbocyclic cyclophilin binding compounds and their use |
| 06/05/2002 | EP1211250A1 C10 taxane derivatives and pharmaceutical compositions |
| 06/05/2002 | EP1210325A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP0891336B1 Substituted 1-methyl-3-benzyluracils |